SI
Spinogenix, Inc.
SEC filingOther Health Care · Los Angeles, CA
Amount raised$10.6Msold at filing
Total offering$35M$24.4M still open
Investors in the raise5count reported to the SEC
FiledMar 9, 2026first sale Nov 21, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Steve YoungDirector
Stella Sarraf, Ph.D.Executive Officer, Director
Jerre L. SteadDirector
Mervyn Turner, Ph.D.Director
Executive officers, directors and promoters as listed on the Form D.